N/A
Manufactured by AvPAK
4,508 FDA adverse event reports analyzed
Last updated: 2026-04-15
UREA is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by AvPAK. The most commonly reported adverse reactions for UREA include DIARRHOEA, FATIGUE, NAUSEA, OFF LABEL USE, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for UREA.
Out of 2,051 classified reports for UREA:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 4,508 FDA FAERS reports that mention UREA. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DIARRHOEA, FATIGUE, NAUSEA, OFF LABEL USE, DRUG INEFFECTIVE, DECREASED APPETITE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list AvPAK in connection with UREA. Always verify the specific product and NDC with your pharmacist.